Sfoglia per Rivista DIABETOLOGIA
Identification of type 1 diabetic patients with insulitis at diagnosis by Tc-99m-IL2 scintigraphy
1998-01-01 Signore, A; Chianelli, M; Visalli, N; Barone, R; Annovazzi, A; Di Leve, G; Parisella, Mg; Pozzilli, P; Grp, Is
Ii-key/MHC class II epitope hybrid technology and ELISPOT as say in type 1 diabetes
2006-01-01 Vadacca, M; Valorani, G; Humphreys, Re; Kallinteris, N; Valente, L; Pozzilli, P; Group, I
Ii-key/MHC class II epitope hybrid technology to detect T cell response to insulin and GAD in type 1 diabetes.
2007-01-01 Vadacca, M; Valorani, G; Humphreys, R; Kallinteris, N; Valente, L; D'Agostino, G; Pozzilli, P; Grp, I.
IMMUNOTHERAPY IN PRE-TYPE-1 DIABETES-MELLITUS
1990-01-01 Bach, Jf; Dupre, J; Eisenbarth, Gs; Harrison, Lc; Maclaren, Nk; Nerup, J; Pozzilli, P
IN-VIVO DETECTION OF ACTIVATED LYMPHOCYTES IN THE ENDOCRINE PANCREAS - A NEW TOOL FOR IDDM PREDICTION
1995-01-01 Signore, A; Chianelli, M; Picarelli, A; Ferretti, E; Greco, M; Multari, M; Demattia, G; Pozzilli, P
IN-VIVO IMAGING OF ACTIVATED LYMPHOCYTES IN THE PANCREAS OF NEWLY-DIAGNOSED DIABETIC-PATIENTS
1993-01-01 Signore, A; Chianelli, M; Ferretti, E; Mather, Sj; Gale, Eam; Pozzilli, P
Incomplete Freund's adjuvant protects NOD mice from type 1 diabetes
1998-01-01 Beales, Pe; Liddi, R; Matta, G; Webb, Gp; Pozzilli, P
Insulin secretion at diagnosis of type 1 diabetes is associated with both age of onset and HLA class II
2005-01-01 Spoletini, M; Petrone, A; Galgani, A; Bassotti, G; Guglielmi, C; Picardi, A; Manfrini, S; Imdiab, G; Pozzilli, P; Buzzetti, R
Intracellular inhibition of JNK kinase reduces lymphocyte homing into endocrine pancreas of non obese diabetic (NOD) mouse
2008-01-01 Khoo, Cp; Hill, N; Valorani, Mg; Signore, A; Pozzilli, P
Investigation of risk factors associated with different HLA genotypes of susceptibility to Type 1 diabetes (The DIABFIN Project).
2003-01-01 Valdes, A; Buzzetti, R; Galgani, A; Visalli, N; Montemari, Al; Bosi, E; Meschi, F; Lorini, R; Minicucci, L; Cristaldi, A; Locatelli, M; Bottazzo, Gf; Pozzilli, P
Isolation of specific bovine beta-casein T cell lines in Type 1 diabetes
2000-01-01 Monetini, L; Cavallo, Mg; Stefanini, L; Coppolino, G; Walk, T; Jung, G; Pozzilli, P
Isolation, characterisation and prospects of endothelial progenitor cells to aid pancreatic beta cell regeneration
2007-01-01 Khoo, Cp; Valorani, Mg; Brittan, M; Alison, Mr; Guglielmi, C; Warnes, G; Johansson, U; Hawa, Mi; Pozzilli, P
Italian experience trial for the implementation of insulin glargine in basal-bolus regimen in patients with type 1 diabetes
2007-01-01 Brunetti, P; Muggeo, M; Cattin, L; Arcangeli, A; Pozzilli, P; Provenzano, V; Francesconi, A; Calatola, P; Santeusanio, F
Leptin levels in the early phases of Type 1 diabetes could explain insulin resistance in the early stages of the disease in female patients
2002-01-01 Coppolino, G; Manfrini, S; Schiaffini, R; Crino, A; Merola, Mk; Valente, L; Visalli, N; Pozzilli, P; Grp, I
Low risk HLA genotype is associated with less destruction of beta cells persisting 12 months after diagnosis
2007-01-01 Spoletini, M; Petrone, A; Capizzi, M; Zavarella, S; Zampetti, S; Leto, G; Alemanno, I; Pozzilli, P; Buzzetti, R
lucose RapidSpray (TM) for a new management of hypoglycaemia in children up to 5 years of age with type 1 diabetes
2008-01-01 Pronina, E; Petraikina, H; Antsiferov, M; Duchareva, O; Guglielmi, C; Khazrai, M; Pozzilli, P
Management of impaired glucose tolerance using buccal spray insulin
2009-01-01 Palermo, A; Napoli, N; Costanza, F; Beretta, G; Manfrini, S; Pozzilli, P
Mapping of IDDM 12 in southern European populations
1998-01-01 Nistico, L; Prichard, L; Buzzetti, R; De Cinti, A; Di Genova, G; Tosi, R; Serrano-Rios, M; Martinez, Mt; Todd, J; Pozzilli, P
A MULTICENTER EUROPEAN STUDY FOR THE EVALUATION OF SPONTANEOUS CLINICAL REMISSION IN IDDM
1995-01-01 Browne, Pd; Amodeo, Bm; Deleeuw, I; Ducaju, Mvl; Ionescutirgoviste, C; Kolouskova, S; Lampeter, E; Linn, T; Ludvigsson, J; Madacsy, L; Mrozikiewicz, A; Mrozikiewicz, D; Pataki, V; Podar, T; Reutershahn, E; Stoppoloni, Gp; Vavrinec, J; Vialettes, B; Yilmaz, T; Pozzilli, P
Multiple sclerosis and Type I diabetes
2002-01-01 Buzzetti, R; Pozzilli, P; Di Mario, U; Ballerini, C; Massacesi, L
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Identification of type 1 diabetic patients with insulitis at diagnosis by Tc-99m-IL2 scintigraphy | 1-gen-1998 | Signore, A; Chianelli, M; Visalli, N; Barone, R; Annovazzi, A; Di Leve, G; Parisella, Mg; Pozzilli, P; Grp, Is | |
Ii-key/MHC class II epitope hybrid technology and ELISPOT as say in type 1 diabetes | 1-gen-2006 | Vadacca, M; Valorani, G; Humphreys, Re; Kallinteris, N; Valente, L; Pozzilli, P; Group, I | |
Ii-key/MHC class II epitope hybrid technology to detect T cell response to insulin and GAD in type 1 diabetes. | 1-gen-2007 | Vadacca, M; Valorani, G; Humphreys, R; Kallinteris, N; Valente, L; D'Agostino, G; Pozzilli, P; Grp, I. | |
IMMUNOTHERAPY IN PRE-TYPE-1 DIABETES-MELLITUS | 1-gen-1990 | Bach, Jf; Dupre, J; Eisenbarth, Gs; Harrison, Lc; Maclaren, Nk; Nerup, J; Pozzilli, P | |
IN-VIVO DETECTION OF ACTIVATED LYMPHOCYTES IN THE ENDOCRINE PANCREAS - A NEW TOOL FOR IDDM PREDICTION | 1-gen-1995 | Signore, A; Chianelli, M; Picarelli, A; Ferretti, E; Greco, M; Multari, M; Demattia, G; Pozzilli, P | |
IN-VIVO IMAGING OF ACTIVATED LYMPHOCYTES IN THE PANCREAS OF NEWLY-DIAGNOSED DIABETIC-PATIENTS | 1-gen-1993 | Signore, A; Chianelli, M; Ferretti, E; Mather, Sj; Gale, Eam; Pozzilli, P | |
Incomplete Freund's adjuvant protects NOD mice from type 1 diabetes | 1-gen-1998 | Beales, Pe; Liddi, R; Matta, G; Webb, Gp; Pozzilli, P | |
Insulin secretion at diagnosis of type 1 diabetes is associated with both age of onset and HLA class II | 1-gen-2005 | Spoletini, M; Petrone, A; Galgani, A; Bassotti, G; Guglielmi, C; Picardi, A; Manfrini, S; Imdiab, G; Pozzilli, P; Buzzetti, R | |
Intracellular inhibition of JNK kinase reduces lymphocyte homing into endocrine pancreas of non obese diabetic (NOD) mouse | 1-gen-2008 | Khoo, Cp; Hill, N; Valorani, Mg; Signore, A; Pozzilli, P | |
Investigation of risk factors associated with different HLA genotypes of susceptibility to Type 1 diabetes (The DIABFIN Project). | 1-gen-2003 | Valdes, A; Buzzetti, R; Galgani, A; Visalli, N; Montemari, Al; Bosi, E; Meschi, F; Lorini, R; Minicucci, L; Cristaldi, A; Locatelli, M; Bottazzo, Gf; Pozzilli, P | |
Isolation of specific bovine beta-casein T cell lines in Type 1 diabetes | 1-gen-2000 | Monetini, L; Cavallo, Mg; Stefanini, L; Coppolino, G; Walk, T; Jung, G; Pozzilli, P | |
Isolation, characterisation and prospects of endothelial progenitor cells to aid pancreatic beta cell regeneration | 1-gen-2007 | Khoo, Cp; Valorani, Mg; Brittan, M; Alison, Mr; Guglielmi, C; Warnes, G; Johansson, U; Hawa, Mi; Pozzilli, P | |
Italian experience trial for the implementation of insulin glargine in basal-bolus regimen in patients with type 1 diabetes | 1-gen-2007 | Brunetti, P; Muggeo, M; Cattin, L; Arcangeli, A; Pozzilli, P; Provenzano, V; Francesconi, A; Calatola, P; Santeusanio, F | |
Leptin levels in the early phases of Type 1 diabetes could explain insulin resistance in the early stages of the disease in female patients | 1-gen-2002 | Coppolino, G; Manfrini, S; Schiaffini, R; Crino, A; Merola, Mk; Valente, L; Visalli, N; Pozzilli, P; Grp, I | |
Low risk HLA genotype is associated with less destruction of beta cells persisting 12 months after diagnosis | 1-gen-2007 | Spoletini, M; Petrone, A; Capizzi, M; Zavarella, S; Zampetti, S; Leto, G; Alemanno, I; Pozzilli, P; Buzzetti, R | |
lucose RapidSpray (TM) for a new management of hypoglycaemia in children up to 5 years of age with type 1 diabetes | 1-gen-2008 | Pronina, E; Petraikina, H; Antsiferov, M; Duchareva, O; Guglielmi, C; Khazrai, M; Pozzilli, P | |
Management of impaired glucose tolerance using buccal spray insulin | 1-gen-2009 | Palermo, A; Napoli, N; Costanza, F; Beretta, G; Manfrini, S; Pozzilli, P | |
Mapping of IDDM 12 in southern European populations | 1-gen-1998 | Nistico, L; Prichard, L; Buzzetti, R; De Cinti, A; Di Genova, G; Tosi, R; Serrano-Rios, M; Martinez, Mt; Todd, J; Pozzilli, P | |
A MULTICENTER EUROPEAN STUDY FOR THE EVALUATION OF SPONTANEOUS CLINICAL REMISSION IN IDDM | 1-gen-1995 | Browne, Pd; Amodeo, Bm; Deleeuw, I; Ducaju, Mvl; Ionescutirgoviste, C; Kolouskova, S; Lampeter, E; Linn, T; Ludvigsson, J; Madacsy, L; Mrozikiewicz, A; Mrozikiewicz, D; Pataki, V; Podar, T; Reutershahn, E; Stoppoloni, Gp; Vavrinec, J; Vialettes, B; Yilmaz, T; Pozzilli, P | |
Multiple sclerosis and Type I diabetes | 1-gen-2002 | Buzzetti, R; Pozzilli, P; Di Mario, U; Ballerini, C; Massacesi, L |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile